Rank | Gene Set | Z-score |
---|---|---|
1 | vocalization behavior (GO:0071625) | 5.80636491 |
2 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 5.79608018 |
3 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 5.70909529 |
4 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 5.62176884 |
5 | locomotory exploration behavior (GO:0035641) | 5.39390916 |
6 | synaptic vesicle exocytosis (GO:0016079) | 5.25947460 |
7 | protein localization to synapse (GO:0035418) | 5.21521047 |
8 | neuron cell-cell adhesion (GO:0007158) | 5.20650065 |
9 | regulation of glutamate receptor signaling pathway (GO:1900449) | 5.16043320 |
10 | glutamate secretion (GO:0014047) | 5.08781291 |
11 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 5.01856005 |
12 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 4.89609875 |
13 | synaptic vesicle maturation (GO:0016188) | 4.89391149 |
14 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 4.81937689 |
15 | regulation of synaptic vesicle exocytosis (GO:2000300) | 4.78642813 |
16 | glutamate receptor signaling pathway (GO:0007215) | 4.70422102 |
17 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 4.70078015 |
18 | neuronal action potential propagation (GO:0019227) | 4.59512502 |
19 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 4.55424822 |
20 | exploration behavior (GO:0035640) | 4.46403712 |
21 | synaptic transmission, glutamatergic (GO:0035249) | 4.41878503 |
22 | neuron-neuron synaptic transmission (GO:0007270) | 4.39098478 |
23 | behavioral response to nicotine (GO:0035095) | 4.32782250 |
24 | presynaptic membrane assembly (GO:0097105) | 4.32108775 |
25 | regulation of synaptic vesicle transport (GO:1902803) | 4.28126178 |
26 | neurotransmitter-gated ion channel clustering (GO:0072578) | 4.25667170 |
27 | regulation of neuronal synaptic plasticity (GO:0048168) | 4.24296137 |
28 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 4.15353394 |
29 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 4.13951030 |
30 | dendritic spine morphogenesis (GO:0060997) | 4.10864957 |
31 | postsynaptic membrane organization (GO:0001941) | 4.07203694 |
32 | neuron recognition (GO:0008038) | 4.00829444 |
33 | neurotransmitter secretion (GO:0007269) | 4.00220949 |
34 | long-term memory (GO:0007616) | 3.96763742 |
35 | regulation of postsynaptic membrane potential (GO:0060078) | 3.95494204 |
36 | long-term synaptic potentiation (GO:0060291) | 3.93084835 |
37 | presynaptic membrane organization (GO:0097090) | 3.90645037 |
38 | positive regulation of membrane potential (GO:0045838) | 3.90317328 |
39 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 3.86102483 |
40 | regulation of dendritic spine morphogenesis (GO:0061001) | 3.85352552 |
41 | regulation of synapse structural plasticity (GO:0051823) | 3.83400818 |
42 | layer formation in cerebral cortex (GO:0021819) | 3.80987675 |
43 | positive regulation of synapse maturation (GO:0090129) | 3.78724603 |
44 | regulation of synaptic plasticity (GO:0048167) | 3.76484287 |
45 | gamma-aminobutyric acid transport (GO:0015812) | 3.71363396 |
46 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 3.68858340 |
47 | response to histamine (GO:0034776) | 3.67406054 |
48 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 3.66705321 |
49 | axonal fasciculation (GO:0007413) | 3.65704322 |
50 | serotonin metabolic process (GO:0042428) | 3.64652282 |
51 | membrane depolarization during action potential (GO:0086010) | 3.61423568 |
52 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 3.60103760 |
53 | positive regulation of neurotransmitter secretion (GO:0001956) | 3.54920438 |
54 | neuronal action potential (GO:0019228) | 3.52396371 |
55 | primary amino compound metabolic process (GO:1901160) | 3.50159101 |
56 | regulation of dendritic spine development (GO:0060998) | 3.48485924 |
57 | transmission of nerve impulse (GO:0019226) | 3.48264880 |
58 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.44508785 |
59 | synaptic vesicle endocytosis (GO:0048488) | 3.42023652 |
60 | behavioral defense response (GO:0002209) | 3.39140482 |
61 | behavioral fear response (GO:0001662) | 3.39140482 |
62 | positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 3.37946764 |
63 | regulation of neurotransmitter secretion (GO:0046928) | 3.37764698 |
64 | behavioral response to cocaine (GO:0048148) | 3.36628794 |
65 | startle response (GO:0001964) | 3.34624488 |
66 | cellular potassium ion homeostasis (GO:0030007) | 3.34191764 |
67 | cerebellar granule cell differentiation (GO:0021707) | 3.32641783 |
68 | neurotransmitter transport (GO:0006836) | 3.32545505 |
69 | auditory behavior (GO:0031223) | 3.29474813 |
70 | proline transport (GO:0015824) | 3.29162370 |
71 | membrane depolarization (GO:0051899) | 3.24696077 |
72 | learning (GO:0007612) | 3.23360544 |
73 | fear response (GO:0042596) | 3.23047892 |
74 | G-protein coupled acetylcholine receptor signaling pathway (GO:0007213) | 3.22526240 |
75 | synapse assembly (GO:0007416) | 3.20766680 |
76 | regulation of vesicle fusion (GO:0031338) | 3.20671773 |
77 | detection of mechanical stimulus involved in sensory perception of sound (GO:0050910) | 3.18700324 |
78 | cerebellar Purkinje cell differentiation (GO:0021702) | 3.18656384 |
79 | dendritic spine organization (GO:0097061) | 3.18382260 |
80 | positive regulation of neurotransmitter transport (GO:0051590) | 3.18319174 |
81 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 3.17600574 |
82 | positive regulation of dendritic spine development (GO:0060999) | 3.15128412 |
83 | long term synaptic depression (GO:0060292) | 3.14826106 |
84 | regulation of respiratory gaseous exchange by neurological system process (GO:0002087) | 3.13745451 |
85 | detection of light stimulus involved in sensory perception (GO:0050962) | 3.11414770 |
86 | detection of light stimulus involved in visual perception (GO:0050908) | 3.11414770 |
87 | negative regulation of synaptic transmission, glutamatergic (GO:0051967) | 3.10712996 |
88 | regulation of hippo signaling (GO:0035330) | 3.10679367 |
89 | regulation of synapse maturation (GO:0090128) | 3.10364266 |
90 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 3.08369776 |
91 | positive regulation of dendritic spine morphogenesis (GO:0061003) | 3.08246932 |
92 | mechanosensory behavior (GO:0007638) | 3.08144861 |
93 | innervation (GO:0060384) | 3.07609097 |
94 | regulation of neurotransmitter transport (GO:0051588) | 3.06537381 |
95 | membrane hyperpolarization (GO:0060081) | 3.05544286 |
96 | positive regulation of synaptic transmission (GO:0050806) | 3.04459331 |
97 | central nervous system projection neuron axonogenesis (GO:0021952) | 3.04058477 |
98 | response to auditory stimulus (GO:0010996) | 3.03567914 |
99 | regulation of glutamate secretion (GO:0014048) | 3.02755887 |
100 | fucose catabolic process (GO:0019317) | 3.02560131 |
101 | L-fucose metabolic process (GO:0042354) | 3.02560131 |
102 | L-fucose catabolic process (GO:0042355) | 3.02560131 |
103 | regulation of neurotransmitter levels (GO:0001505) | 3.02494090 |
104 | regulation of synaptic transmission (GO:0050804) | 3.00650608 |
105 | intraspecies interaction between organisms (GO:0051703) | 3.00504396 |
106 | social behavior (GO:0035176) | 3.00504396 |
107 | negative regulation of translation involved in gene silencing by miRNA (GO:0035278) | 3.00294647 |
108 | negative regulation of translation, ncRNA-mediated (GO:0040033) | 3.00294647 |
109 | regulation of translation, ncRNA-mediated (GO:0045974) | 3.00294647 |
110 | neuromuscular process controlling balance (GO:0050885) | 2.98618331 |
111 | detection of calcium ion (GO:0005513) | 2.98436173 |
112 | regulation of voltage-gated calcium channel activity (GO:1901385) | 2.97769979 |
113 | synaptic transmission (GO:0007268) | 2.96730684 |
114 | cochlea development (GO:0090102) | 2.96726700 |
115 | dendrite morphogenesis (GO:0048813) | 2.95876312 |
116 | positive regulation of synaptic transmission, GABAergic (GO:0032230) | 2.95792017 |
117 | indole-containing compound metabolic process (GO:0042430) | 2.91270184 |
118 | behavioral response to ethanol (GO:0048149) | 2.89956142 |
119 | atrial cardiac muscle cell action potential (GO:0086014) | 2.89171189 |
120 | tryptophan catabolic process (GO:0006569) | 2.87428049 |
121 | indole-containing compound catabolic process (GO:0042436) | 2.87428049 |
122 | indolalkylamine catabolic process (GO:0046218) | 2.87428049 |
123 | action potential (GO:0001508) | 2.86469942 |
124 | regulation of action potential (GO:0098900) | 2.84775990 |
125 | kynurenine metabolic process (GO:0070189) | 2.83440072 |
126 | positive regulation of sodium ion transmembrane transporter activity (GO:2000651) | 2.83136017 |
127 | reflex (GO:0060004) | 2.80474001 |
128 | retinal cone cell development (GO:0046549) | 2.73494635 |
129 | positive regulation of phosphoprotein phosphatase activity (GO:0032516) | 2.72987212 |
130 | urinary tract smooth muscle contraction (GO:0014848) | 2.72843256 |
131 | indolalkylamine metabolic process (GO:0006586) | 2.69538646 |
132 | cAMP catabolic process (GO:0006198) | 2.68933228 |
133 | regulation of neurotransmitter uptake (GO:0051580) | 2.68170471 |
134 | detection of mechanical stimulus involved in sensory perception (GO:0050974) | 2.66534337 |
135 | regulation of gene silencing by RNA (GO:0060966) | 2.66207682 |
136 | regulation of posttranscriptional gene silencing (GO:0060147) | 2.66207682 |
137 | regulation of gene silencing by miRNA (GO:0060964) | 2.66207682 |
138 | axon ensheathment in central nervous system (GO:0032291) | 2.65615272 |
139 | central nervous system myelination (GO:0022010) | 2.65615272 |
140 | peristalsis (GO:0030432) | 2.65491034 |
141 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 2.62965103 |
142 | cellular potassium ion transport (GO:0071804) | 2.61775878 |
143 | potassium ion transmembrane transport (GO:0071805) | 2.61775878 |
144 | epithelial cilium movement involved in determination of left/right asymmetry (GO:0060287) | 2.61749387 |
145 | adult walking behavior (GO:0007628) | 2.60760113 |
146 | positive regulation of sodium ion transmembrane transport (GO:1902307) | 2.59157961 |
147 | cyclic nucleotide catabolic process (GO:0009214) | 2.58125836 |
148 | neuromuscular synaptic transmission (GO:0007274) | 2.57110102 |
149 | C4-dicarboxylate transport (GO:0015740) | 2.57075518 |
150 | multicellular organismal signaling (GO:0035637) | 2.57045953 |
151 | regulation of calcium ion-dependent exocytosis (GO:0017158) | 2.56204454 |
152 | inner ear receptor stereocilium organization (GO:0060122) | 2.53293762 |
153 | auditory receptor cell stereocilium organization (GO:0060088) | 2.52796443 |
154 | sulfation (GO:0051923) | 2.50876833 |
155 | central nervous system neuron axonogenesis (GO:0021955) | 2.49042790 |
156 | potassium ion transport (GO:0006813) | 2.47391138 |
157 | neural tube formation (GO:0001841) | 2.46989188 |
158 | kidney morphogenesis (GO:0060993) | 2.46897568 |
Rank | Gene Set | Z-score |
---|---|---|
1 | EZH2_22144423_ChIP-Seq_EOC_Human | 5.94199149 |
2 | GBX2_23144817_ChIP-Seq_PC3_Human | 4.12474909 |
3 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 3.07266532 |
4 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 3.04038217 |
5 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.94502295 |
6 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.59599821 |
7 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.56926990 |
8 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.56926990 |
9 | REST_21632747_ChIP-Seq_MESCs_Mouse | 2.47096915 |
10 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.45043396 |
11 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.43689465 |
12 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.42090535 |
13 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.38758587 |
14 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.34915364 |
15 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.31450607 |
16 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.27529579 |
17 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 2.25819262 |
18 | TAF15_26573619_Chip-Seq_HEK293_Human | 2.20505193 |
19 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.20189519 |
20 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 2.09472478 |
21 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 2.08879755 |
22 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 2.06827974 |
23 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 2.06157449 |
24 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 2.05674979 |
25 | AR_21572438_ChIP-Seq_LNCaP_Human | 2.03301658 |
26 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.96719865 |
27 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.96571305 |
28 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.92657195 |
29 | * SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.87932309 |
30 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.87887009 |
31 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.84773591 |
32 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.74177588 |
33 | P300_19829295_ChIP-Seq_ESCs_Human | 1.71099735 |
34 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.68454232 |
35 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.67675580 |
36 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.64192104 |
37 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.63174553 |
38 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.59012655 |
39 | EWS_26573619_Chip-Seq_HEK293_Human | 1.57737343 |
40 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.54048428 |
41 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.53597124 |
42 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.53141824 |
43 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.53116523 |
44 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.51581516 |
45 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.47257110 |
46 | FUS_26573619_Chip-Seq_HEK293_Human | 1.46309528 |
47 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.45678757 |
48 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.45656342 |
49 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.44939221 |
50 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.41818104 |
51 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.40570175 |
52 | AR_25329375_ChIP-Seq_VCAP_Human | 1.37715270 |
53 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.37553829 |
54 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.36743874 |
55 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.36572118 |
56 | STAT3_23295773_ChIP-Seq_U87_Human | 1.35730232 |
57 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.34899836 |
58 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.34462518 |
59 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.34422885 |
60 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.34406049 |
61 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.33095304 |
62 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.32605408 |
63 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.29934549 |
64 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.29387225 |
65 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.28616638 |
66 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.28616638 |
67 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.27028364 |
68 | VDR_22108803_ChIP-Seq_LS180_Human | 1.24447473 |
69 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.23770585 |
70 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.23549161 |
71 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.23532328 |
72 | TP53_16413492_ChIP-PET_HCT116_Human | 1.23267761 |
73 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.22990667 |
74 | TCF4_23295773_ChIP-Seq_U87_Human | 1.22516312 |
75 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.21531159 |
76 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.21316245 |
77 | TCF4_22108803_ChIP-Seq_LS180_Human | 1.20486290 |
78 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.19452474 |
79 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 1.19281767 |
80 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.17793309 |
81 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.17524390 |
82 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 1.16871432 |
83 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.16522297 |
84 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.16170242 |
85 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 1.16022921 |
86 | AR_19668381_ChIP-Seq_PC3_Human | 1.16001630 |
87 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.14568203 |
88 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.14291372 |
89 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.13407177 |
90 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.11665841 |
91 | KDM2B_26808549_Chip-Seq_REH_Human | 1.10904570 |
92 | * RUNX2_22187159_ChIP-Seq_PCA_Human | 1.10531252 |
93 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.09807126 |
94 | RXR_22108803_ChIP-Seq_LS180_Human | 1.09048724 |
95 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.08983015 |
96 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.08983015 |
97 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 1.08163981 |
98 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.07960578 |
99 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.07932407 |
100 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.07749316 |
101 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.07460829 |
102 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 1.06731032 |
103 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 1.05092702 |
104 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.04870908 |
105 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 1.04480117 |
106 | SMAD3_21741376_ChIP-Seq_ESCs_Human | 1.03538522 |
107 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.03535200 |
108 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.02323309 |
109 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.01980594 |
110 | TAL1_21186366_ChIP-Seq_BM-HSCs_Mouse | 1.01808675 |
111 | NANOG_19829295_ChIP-Seq_ESCs_Human | 1.01462956 |
112 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.01147565 |
113 | JUN_21703547_ChIP-Seq_K562_Human | 1.00898551 |
114 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 1.00372359 |
115 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.00350518 |
116 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.99846587 |
117 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.95816727 |
118 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 0.95555369 |
119 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.95488271 |
120 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 0.94604060 |
121 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.93915862 |
122 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.92671460 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0004859_abnormal_synaptic_plasticity | 6.54201447 |
2 | MP0003880_abnormal_central_pattern | 5.45488466 |
3 | MP0003635_abnormal_synaptic_transmissio | 4.25803789 |
4 | MP0004270_analgesia | 3.83623286 |
5 | MP0009745_abnormal_behavioral_response | 3.60188590 |
6 | MP0002063_abnormal_learning/memory/cond | 3.48501376 |
7 | MP0002064_seizures | 3.19246251 |
8 | MP0001968_abnormal_touch/_nociception | 3.09975924 |
9 | MP0009046_muscle_twitch | 3.06034750 |
10 | MP0002572_abnormal_emotion/affect_behav | 2.97967604 |
11 | MP0001486_abnormal_startle_reflex | 2.70132391 |
12 | MP0002822_catalepsy | 2.65734302 |
13 | MP0002272_abnormal_nervous_system | 2.63300941 |
14 | MP0002734_abnormal_mechanical_nocicepti | 2.55630433 |
15 | MP0008877_abnormal_DNA_methylation | 2.42588157 |
16 | MP0005423_abnormal_somatic_nervous | 2.38830469 |
17 | MP0002736_abnormal_nociception_after | 2.33799127 |
18 | MP0001501_abnormal_sleep_pattern | 2.33796932 |
19 | MP0002735_abnormal_chemical_nociception | 2.23330382 |
20 | MP0001440_abnormal_grooming_behavior | 2.17675839 |
21 | MP0009780_abnormal_chondrocyte_physiolo | 2.12353870 |
22 | MP0002067_abnormal_sensory_capabilities | 2.06373544 |
23 | MP0000778_abnormal_nervous_system | 1.99245241 |
24 | MP0003195_calcinosis | 1.89123456 |
25 | MP0002733_abnormal_thermal_nociception | 1.87366726 |
26 | MP0001970_abnormal_pain_threshold | 1.84503274 |
27 | MP0004924_abnormal_behavior | 1.82849228 |
28 | MP0005386_behavior/neurological_phenoty | 1.82849228 |
29 | MP0002557_abnormal_social/conspecific_i | 1.81719765 |
30 | MP0002184_abnormal_innervation | 1.81670723 |
31 | MP0001984_abnormal_olfaction | 1.81276743 |
32 | MP0001188_hyperpigmentation | 1.79773531 |
33 | MP0004043_abnormal_pH_regulation | 1.78689006 |
34 | MP0005646_abnormal_pituitary_gland | 1.75167133 |
35 | MP0003329_amyloid_beta_deposits | 1.72466165 |
36 | MP0003646_muscle_fatigue | 1.68706181 |
37 | MP0008569_lethality_at_weaning | 1.68331506 |
38 | MP0003879_abnormal_hair_cell | 1.66425599 |
39 | MP0004147_increased_porphyrin_level | 1.65044374 |
40 | MP0004811_abnormal_neuron_physiology | 1.62350876 |
41 | MP0006276_abnormal_autonomic_nervous | 1.55196934 |
42 | MP0001529_abnormal_vocalization | 1.54444366 |
43 | MP0001986_abnormal_taste_sensitivity | 1.53664889 |
44 | MP0003787_abnormal_imprinting | 1.53457413 |
45 | MP0002909_abnormal_adrenal_gland | 1.44771958 |
46 | MP0000955_abnormal_spinal_cord | 1.43846950 |
47 | MP0000427_abnormal_hair_cycle | 1.39245370 |
48 | MP0002066_abnormal_motor_capabilities/c | 1.39207441 |
49 | MP0002882_abnormal_neuron_morphology | 1.39119577 |
50 | MP0003890_abnormal_embryonic-extraembry | 1.36046876 |
51 | MP0001905_abnormal_dopamine_level | 1.31117559 |
52 | MP0003633_abnormal_nervous_system | 1.31016288 |
53 | MP0004885_abnormal_endolymph | 1.27887157 |
54 | MP0004858_abnormal_nervous_system | 1.27818759 |
55 | MP0001502_abnormal_circadian_rhythm | 1.23547710 |
56 | MP0005645_abnormal_hypothalamus_physiol | 1.19258225 |
57 | MP0004133_heterotaxia | 1.17088975 |
58 | MP0005174_abnormal_tail_pigmentation | 1.16140792 |
59 | MP0005409_darkened_coat_color | 1.14369870 |
60 | MP0005253_abnormal_eye_physiology | 1.14107905 |
61 | MP0003631_nervous_system_phenotype | 1.12880744 |
62 | MP0002152_abnormal_brain_morphology | 1.10664703 |
63 | MP0005551_abnormal_eye_electrophysiolog | 1.09125538 |
64 | MP0004742_abnormal_vestibular_system | 1.08401050 |
65 | MP0003136_yellow_coat_color | 1.06498013 |
66 | MP0004145_abnormal_muscle_electrophysio | 1.05009745 |
67 | MP0004142_abnormal_muscle_tone | 1.03650243 |
68 | MP0004130_abnormal_muscle_cell | 1.03332916 |
69 | MP0010386_abnormal_urinary_bladder | 1.02918719 |
70 | MP0000569_abnormal_digit_pigmentation | 0.99541607 |
71 | MP0003119_abnormal_digestive_system | 0.99296879 |
72 | MP0002837_dystrophic_cardiac_calcinosis | 0.95714892 |
73 | MP0008874_decreased_physiological_sensi | 0.94921871 |
74 | MP0001963_abnormal_hearing_physiology | 0.93169372 |
75 | MP0008872_abnormal_physiological_respon | 0.92172524 |
76 | MP0002928_abnormal_bile_duct | 0.91953773 |
77 | MP0002876_abnormal_thyroid_physiology | 0.91613722 |
78 | MP0002229_neurodegeneration | 0.91235691 |
79 | MP0000383_abnormal_hair_follicle | 0.91225662 |
80 | MP0006072_abnormal_retinal_apoptosis | 0.89210221 |
81 | MP0001177_atelectasis | 0.88677463 |
82 | MP0002234_abnormal_pharynx_morphology | 0.88592245 |
83 | MP0003121_genomic_imprinting | 0.87639632 |
84 | MP0002069_abnormal_eating/drinking_beha | 0.86883380 |
85 | MP0002653_abnormal_ependyma_morphology | 0.86313718 |
86 | MP0004085_abnormal_heartbeat | 0.85659314 |
87 | MP0000631_abnormal_neuroendocrine_gland | 0.84788714 |
88 | MP0004484_altered_response_of | 0.84296051 |
89 | MP0005167_abnormal_blood-brain_barrier | 0.81731286 |
90 | MP0005499_abnormal_olfactory_system | 0.81165156 |
91 | MP0005394_taste/olfaction_phenotype | 0.81165156 |
92 | MP0002938_white_spotting | 0.80936853 |
93 | MP0000230_abnormal_systemic_arterial | 0.80715364 |
94 | MP0002160_abnormal_reproductive_system | 0.80316816 |
95 | MP0003122_maternal_imprinting | 0.79540946 |
96 | MP0003283_abnormal_digestive_organ | 0.78503505 |
97 | MP0002752_abnormal_somatic_nervous | 0.77071256 |
98 | MP0003632_abnormal_nervous_system | 0.76672445 |
99 | MP0005187_abnormal_penis_morphology | 0.76483411 |
100 | MP0003878_abnormal_ear_physiology | 0.75382612 |
101 | MP0005377_hearing/vestibular/ear_phenot | 0.75382612 |
102 | MP0005195_abnormal_posterior_eye | 0.75148205 |
103 | MP0005171_absent_coat_pigmentation | 0.75093561 |
104 | MP0001485_abnormal_pinna_reflex | 0.74996191 |
105 | MP0008875_abnormal_xenobiotic_pharmacok | 0.74977438 |
106 | MP0000920_abnormal_myelination | 0.74297874 |
107 | MP0004215_abnormal_myocardial_fiber | 0.74155589 |
108 | MP0000751_myopathy | 0.73638823 |
109 | MP0005535_abnormal_body_temperature | 0.73033682 |
110 | MP0002751_abnormal_autonomic_nervous | 0.69712704 |
111 | MP0000604_amyloidosis | 0.69603216 |
112 | MP0003634_abnormal_glial_cell | 0.68028880 |
113 | MP0001664_abnormal_digestion | 0.67015696 |
114 | MP0000013_abnormal_adipose_tissue | 0.66025003 |
115 | MP0006292_abnormal_olfactory_placode | 0.64311846 |
116 | MP0002090_abnormal_vision | 0.62457830 |
117 | MP0003075_altered_response_to | 0.62428729 |
118 | MP0004510_myositis | 0.60657337 |
119 | MP0000026_abnormal_inner_ear | 0.60213545 |
120 | MP0003690_abnormal_glial_cell | 0.59098969 |
121 | MP0003861_abnormal_nervous_system | 0.56605786 |
122 | MP0002102_abnormal_ear_morphology | 0.56245195 |
123 | MP0003137_abnormal_impulse_conducting | 0.55708745 |
124 | MP0001943_abnormal_respiration | 0.54031136 |
125 | MP0004233_abnormal_muscle_weight | 0.51651071 |
126 | MP0005623_abnormal_meninges_morphology | 0.51479378 |
127 | MP0002638_abnormal_pupillary_reflex | 0.50538708 |
128 | MP0002082_postnatal_lethality | 0.50022879 |
129 | MP0010770_preweaning_lethality | 0.50022879 |
130 | MP0010769_abnormal_survival | 0.49649321 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Focal motor seizures (HP:0011153) | 9.39925022 |
2 | Focal seizures (HP:0007359) | 6.32752907 |
3 | Myokymia (HP:0002411) | 6.17257306 |
4 | Epileptic encephalopathy (HP:0200134) | 6.05440064 |
5 | Febrile seizures (HP:0002373) | 5.15949332 |
6 | Atonic seizures (HP:0010819) | 5.10468797 |
7 | Visual hallucinations (HP:0002367) | 5.09375176 |
8 | Absence seizures (HP:0002121) | 4.72383551 |
9 | Dialeptic seizures (HP:0011146) | 4.39909191 |
10 | Progressive cerebellar ataxia (HP:0002073) | 4.29541987 |
11 | Generalized tonic-clonic seizures (HP:0002069) | 4.26935670 |
12 | Pancreatic cysts (HP:0001737) | 3.94712916 |
13 | Gaze-evoked nystagmus (HP:0000640) | 3.83675911 |
14 | * Broad-based gait (HP:0002136) | 3.83204693 |
15 | Pancreatic fibrosis (HP:0100732) | 3.59965106 |
16 | * Hyperventilation (HP:0002883) | 3.42570713 |
17 | Amblyopia (HP:0000646) | 3.40361262 |
18 | Abnormality of midbrain morphology (HP:0002418) | 3.39175080 |
19 | Molar tooth sign on MRI (HP:0002419) | 3.39175080 |
20 | Congenital stationary night blindness (HP:0007642) | 3.36693986 |
21 | True hermaphroditism (HP:0010459) | 3.32828341 |
22 | Action tremor (HP:0002345) | 3.32543485 |
23 | Dysdiadochokinesis (HP:0002075) | 3.29394104 |
24 | Supranuclear gaze palsy (HP:0000605) | 3.26751229 |
25 | Nephronophthisis (HP:0000090) | 3.22210628 |
26 | * Poor eye contact (HP:0000817) | 3.22009299 |
27 | Impaired vibration sensation in the lower limbs (HP:0002166) | 3.21194378 |
28 | Dysmetria (HP:0001310) | 3.17166194 |
29 | Truncal ataxia (HP:0002078) | 3.10086849 |
30 | Urinary bladder sphincter dysfunction (HP:0002839) | 3.08246985 |
31 | Cerebral inclusion bodies (HP:0100314) | 3.07822566 |
32 | Progressive inability to walk (HP:0002505) | 3.00093723 |
33 | * Drooling (HP:0002307) | 2.95049764 |
34 | * Excessive salivation (HP:0003781) | 2.95049764 |
35 | Anxiety (HP:0000739) | 2.89450189 |
36 | Mutism (HP:0002300) | 2.89294605 |
37 | Neurofibrillary tangles (HP:0002185) | 2.88808373 |
38 | Scanning speech (HP:0002168) | 2.87765482 |
39 | Birth length less than 3rd percentile (HP:0003561) | 2.86941566 |
40 | Abnormality of the renal medulla (HP:0100957) | 2.85922241 |
41 | Depression (HP:0000716) | 2.84552617 |
42 | * Impaired social interactions (HP:0000735) | 2.82952120 |
43 | * Abnormal social behavior (HP:0012433) | 2.82952120 |
44 | Type II lissencephaly (HP:0007260) | 2.81269752 |
45 | Genetic anticipation (HP:0003743) | 2.80939643 |
46 | Abnormality of the renal cortex (HP:0011035) | 2.78202657 |
47 | Impaired smooth pursuit (HP:0007772) | 2.73329429 |
48 | Ankle clonus (HP:0011448) | 2.72690312 |
49 | Papilledema (HP:0001085) | 2.63936178 |
50 | Hemiparesis (HP:0001269) | 2.63462028 |
51 | Diplopia (HP:0000651) | 2.63312239 |
52 | Abnormality of binocular vision (HP:0011514) | 2.63312239 |
53 | * Epileptiform EEG discharges (HP:0011182) | 2.63177647 |
54 | Cystic liver disease (HP:0006706) | 2.59374049 |
55 | Abnormal eating behavior (HP:0100738) | 2.59088723 |
56 | Fetal akinesia sequence (HP:0001989) | 2.57645361 |
57 | Attenuation of retinal blood vessels (HP:0007843) | 2.57627628 |
58 | Tubular atrophy (HP:0000092) | 2.56975472 |
59 | Postural instability (HP:0002172) | 2.55894547 |
60 | Termporal pattern (HP:0011008) | 2.53833023 |
61 | Insidious onset (HP:0003587) | 2.53833023 |
62 | Abnormality of the corticospinal tract (HP:0002492) | 2.53509415 |
63 | Polydipsia (HP:0001959) | 2.53384289 |
64 | Abnormal drinking behavior (HP:0030082) | 2.53384289 |
65 | Chronic hepatic failure (HP:0100626) | 2.47705118 |
66 | * Stereotypic behavior (HP:0000733) | 2.46529363 |
67 | Urinary urgency (HP:0000012) | 2.42421305 |
68 | * Absent speech (HP:0001344) | 2.41183233 |
69 | Aplasia/Hypoplasia of the tibia (HP:0005772) | 2.36784413 |
70 | Spastic gait (HP:0002064) | 2.36692856 |
71 | * Inability to walk (HP:0002540) | 2.35827961 |
72 | * EEG with generalized epileptiform discharges (HP:0011198) | 2.35680523 |
73 | Status epilepticus (HP:0002133) | 2.34357127 |
74 | Torticollis (HP:0000473) | 2.33016009 |
75 | Abolished electroretinogram (ERG) (HP:0000550) | 2.32080564 |
76 | Intention tremor (HP:0002080) | 2.30656800 |
77 | Lissencephaly (HP:0001339) | 2.29409956 |
78 | Abnormality of ocular smooth pursuit (HP:0000617) | 2.28429645 |
79 | Dysmetric saccades (HP:0000641) | 2.27489916 |
80 | Genital tract atresia (HP:0001827) | 2.25197632 |
81 | Impaired vibratory sensation (HP:0002495) | 2.24913996 |
82 | Decreased circulating renin level (HP:0003351) | 2.24226436 |
83 | Keratoconus (HP:0000563) | 2.23990276 |
84 | Increased corneal curvature (HP:0100692) | 2.23990276 |
85 | Bradykinesia (HP:0002067) | 2.23155229 |
86 | Optic nerve hypoplasia (HP:0000609) | 2.21214205 |
87 | Gait imbalance (HP:0002141) | 2.18601470 |
88 | Vaginal atresia (HP:0000148) | 2.17466244 |
89 | Decreased central vision (HP:0007663) | 2.17458476 |
90 | Focal dystonia (HP:0004373) | 2.17040658 |
91 | Aplasia/Hypoplasia of the pubic bone (HP:0009104) | 2.14583137 |
92 | Thickened helices (HP:0000391) | 2.14035955 |
93 | Abnormality of alanine metabolism (HP:0010916) | 2.12959936 |
94 | Hyperalaninemia (HP:0003348) | 2.12959936 |
95 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 2.12959936 |
96 | Patellar aplasia (HP:0006443) | 2.12948238 |
97 | * Hypsarrhythmia (HP:0002521) | 2.08729430 |
98 | Aplasia/Hypoplasia of the optic nerve (HP:0008058) | 2.07813712 |
99 | Furrowed tongue (HP:0000221) | 2.06355480 |
100 | Obstructive sleep apnea (HP:0002870) | 2.06118984 |
101 | * Abnormality of salivation (HP:0100755) | 2.05857904 |
102 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 2.05795921 |
103 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 2.05795921 |
104 | Absent/shortened dynein arms (HP:0200106) | 2.03635154 |
105 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 2.03635154 |
106 | Stomach cancer (HP:0012126) | 2.02924037 |
107 | Lower limb muscle weakness (HP:0007340) | 2.02432133 |
108 | Polyphagia (HP:0002591) | 2.02144393 |
109 | Megalencephaly (HP:0001355) | 2.02135386 |
110 | Pendular nystagmus (HP:0012043) | 2.01283428 |
111 | Large for gestational age (HP:0001520) | 1.99389943 |
112 | Nephrogenic diabetes insipidus (HP:0009806) | 1.98407905 |
113 | Chorioretinal atrophy (HP:0000533) | 1.98393567 |
114 | Incomplete penetrance (HP:0003829) | 1.98261885 |
115 | Aplasia/Hypoplasia of the patella (HP:0006498) | 1.97219767 |
116 | Prolonged QT interval (HP:0001657) | 1.97084115 |
117 | Lower limb amyotrophy (HP:0007210) | 1.95008593 |
118 | Cerebellar dysplasia (HP:0007033) | 1.93206863 |
119 | Poor coordination (HP:0002370) | 1.91247304 |
120 | Amyotrophic lateral sclerosis (HP:0007354) | 1.91157582 |
121 | * Generalized myoclonic seizures (HP:0002123) | 1.90461237 |
122 | Sclerocornea (HP:0000647) | 1.90405946 |
123 | Polyuria (HP:0000103) | 1.89183912 |
124 | Hypoplastic labia majora (HP:0000059) | 1.88823953 |
125 | Hyperthyroidism (HP:0000836) | 1.87760125 |
126 | Craniofacial dystonia (HP:0012179) | 1.87553915 |
127 | Abnormality of the labia minora (HP:0012880) | 1.85623775 |
128 | Congenital hepatic fibrosis (HP:0002612) | 1.84742643 |
129 | Aplasia/Hypoplasia of the tongue (HP:0010295) | 1.83422969 |
130 | Limb dystonia (HP:0002451) | 1.83046154 |
131 | Abnormality of the lower motor neuron (HP:0002366) | 1.81658209 |
132 | Oligodactyly (hands) (HP:0001180) | 1.81321092 |
133 | Congenital sensorineural hearing impairment (HP:0008527) | 1.79984813 |
134 | Aqueductal stenosis (HP:0002410) | 1.79525398 |
135 | Hemiplegia (HP:0002301) | 1.79484362 |
136 | * Protruding tongue (HP:0010808) | 1.77913400 |
137 | Akinesia (HP:0002304) | 1.77858910 |
138 | Bulbous nose (HP:0000414) | 1.77632369 |
139 | Long nose (HP:0003189) | 1.77602846 |
140 | Abnormality of the pubic bones (HP:0003172) | 1.76771442 |
141 | Delusions (HP:0000746) | 1.76173548 |
142 | Psychosis (HP:0000709) | 1.75387876 |
143 | Specific learning disability (HP:0001328) | 1.75270889 |
144 | Syncope (HP:0001279) | 1.74945083 |
145 | * Gait ataxia (HP:0002066) | 1.74714464 |
146 | Bony spicule pigmentary retinopathy (HP:0007737) | 1.73514859 |
147 | Abnormality of the labia majora (HP:0012881) | 1.73497626 |
148 | Partial agenesis of the corpus callosum (HP:0001338) | 1.73483856 |
149 | Retinal dysplasia (HP:0007973) | 1.73267113 |
150 | Anencephaly (HP:0002323) | 1.72985701 |
151 | Agitation (HP:0000713) | 1.72921413 |
152 | Hypoplastic ischia (HP:0003175) | 1.72896838 |
153 | Pachygyria (HP:0001302) | 1.72356597 |
154 | Abnormality of the ischium (HP:0003174) | 1.72240754 |
155 | * Blue irides (HP:0000635) | 1.72195561 |
156 | Congenital primary aphakia (HP:0007707) | 1.70103305 |
157 | Medial flaring of the eyebrow (HP:0010747) | 1.68815388 |
158 | Decreased number of large peripheral myelinated nerve fibers (HP:0003387) | 1.67022656 |
159 | Dyskinesia (HP:0100660) | 1.66965867 |
160 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 1.66858417 |
161 | Pheochromocytoma (HP:0002666) | 1.65386234 |
162 | Lower limb asymmetry (HP:0100559) | 1.60608130 |
163 | Sleep apnea (HP:0010535) | 1.58744511 |
164 | * Deeply set eye (HP:0000490) | 1.58399487 |
Rank | Gene Set | Z-score |
---|---|---|
1 | FRK | 5.99566497 |
2 | EPHA4 | 5.08165191 |
3 | NTRK3 | 4.46090523 |
4 | MAP3K9 | 3.36959516 |
5 | MAP3K4 | 3.06670361 |
6 | MARK1 | 3.04773091 |
7 | CASK | 3.03797952 |
8 | BMPR1B | 3.01809650 |
9 | ACVR1B | 2.91750527 |
10 | MAP2K7 | 2.86133664 |
11 | RIPK4 | 2.79403290 |
12 | DAPK2 | 2.54740028 |
13 | MINK1 | 2.33618557 |
14 | ADRBK2 | 2.32131007 |
15 | MAP3K12 | 2.18722483 |
16 | PLK2 | 1.97980525 |
17 | INSRR | 1.91499593 |
18 | MAP2K4 | 1.90493619 |
19 | GRK1 | 1.88030391 |
20 | PAK6 | 1.84471060 |
21 | DAPK1 | 1.80410352 |
22 | NTRK2 | 1.77349261 |
23 | TNIK | 1.73082623 |
24 | WNK4 | 1.70608395 |
25 | CDK19 | 1.70209848 |
26 | PNCK | 1.65801554 |
27 | KSR2 | 1.65291244 |
28 | KSR1 | 1.59964810 |
29 | BMPR2 | 1.53629935 |
30 | NTRK1 | 1.52309355 |
31 | MAP4K2 | 1.49899478 |
32 | SIK2 | 1.49536939 |
33 | CAMKK1 | 1.47877762 |
34 | ZAK | 1.47759503 |
35 | CDK5 | 1.45784394 |
36 | PRPF4B | 1.44500848 |
37 | MAPK13 | 1.33132544 |
38 | CAMKK2 | 1.28183662 |
39 | GRK5 | 1.28087711 |
40 | TLK1 | 1.26859609 |
41 | PRKD3 | 1.26792338 |
42 | STK39 | 1.25908930 |
43 | CAMK1D | 1.24628994 |
44 | MAP3K13 | 1.22778825 |
45 | FES | 1.21213580 |
46 | TAOK3 | 1.19174275 |
47 | MKNK2 | 1.18962430 |
48 | PRKCG | 1.16449098 |
49 | PIK3CA | 1.14314169 |
50 | CAMK2A | 1.13330635 |
51 | OXSR1 | 1.12578767 |
52 | CCNB1 | 1.11321406 |
53 | STK38L | 1.08503753 |
54 | NUAK1 | 1.07751417 |
55 | ADRBK1 | 1.06607808 |
56 | ARAF | 1.03378047 |
57 | PTK2B | 1.00322864 |
58 | CAMK2B | 0.97081503 |
59 | MAP3K2 | 0.95997587 |
60 | STK38 | 0.90582942 |
61 | WNK1 | 0.89103546 |
62 | CAMK1 | 0.88051073 |
63 | TGFBR1 | 0.85540232 |
64 | RAF1 | 0.82353723 |
65 | SGK223 | 0.81845020 |
66 | SGK494 | 0.81845020 |
67 | STK11 | 0.80553441 |
68 | SGK1 | 0.77550547 |
69 | AKT3 | 0.77336297 |
70 | CDK18 | 0.76698108 |
71 | UHMK1 | 0.76557361 |
72 | FGR | 0.76225752 |
73 | CDK14 | 0.75380088 |
74 | SGK2 | 0.74319596 |
75 | CDK15 | 0.73104109 |
76 | DYRK1A | 0.71560736 |
77 | LATS2 | 0.70287972 |
78 | PHKG2 | 0.67753651 |
79 | PHKG1 | 0.67753651 |
80 | TYRO3 | 0.67691999 |
81 | PRKCE | 0.67233518 |
82 | PAK3 | 0.66692663 |
83 | CAMK4 | 0.64743996 |
84 | TAOK1 | 0.63233592 |
85 | CDK11A | 0.62709006 |
86 | CSNK1G2 | 0.62252426 |
87 | SIK3 | 0.58698196 |
88 | MUSK | 0.58395187 |
89 | PDPK1 | 0.58217527 |
90 | MAP3K6 | 0.57427822 |
91 | PDK1 | 0.56979242 |
92 | RET | 0.56718173 |
93 | NME1 | 0.56561591 |
94 | NEK6 | 0.56420823 |
95 | MARK2 | 0.55187571 |
96 | DYRK2 | 0.53220442 |
97 | CAMK1G | 0.52545315 |
98 | CAMK2D | 0.52308196 |
99 | TNK2 | 0.51243592 |
100 | SGK3 | 0.51228491 |
101 | FER | 0.51022822 |
102 | MAPK15 | 0.50176986 |
103 | TIE1 | 0.49801357 |
104 | MAPKAPK5 | 0.49331381 |
105 | MAPK12 | 0.48344098 |
106 | PRKCZ | 0.47847219 |
107 | PRKCH | 0.47106960 |
108 | BCR | 0.46333211 |
109 | PKN1 | 0.44879946 |
110 | DMPK | 0.44747416 |
111 | MAP2K6 | 0.44470507 |
112 | CSNK1D | 0.43501011 |
113 | CSNK1A1L | 0.43340702 |
114 | MAP3K1 | 0.43088955 |
115 | FYN | 0.42692463 |
116 | WNK3 | 0.41432805 |
117 | PRKAA2 | 0.41103481 |
118 | PRKACA | 0.40283950 |
119 | PRKAA1 | 0.40099730 |
120 | PRKG1 | 0.39861290 |
121 | PINK1 | 0.39611672 |
122 | CAMK2G | 0.39316546 |
123 | RPS6KA3 | 0.39279663 |
124 | ERBB3 | 0.39243814 |
125 | CSNK1G1 | 0.39164931 |
126 | CSNK1A1 | 0.39006576 |
127 | LATS1 | 0.38933652 |
128 | FGFR2 | 0.38019037 |
129 | BRAF | 0.37250991 |
130 | TXK | 0.37121031 |
131 | MAP3K7 | 0.37035230 |
132 | MAPK10 | 0.36939516 |
133 | OBSCN | 0.36297421 |
134 | ERBB2 | 0.35053570 |
135 | STK3 | 0.34809803 |
136 | PRKCA | 0.34785365 |
137 | MAPK7 | 0.33276591 |
138 | PRKCQ | 0.32634761 |
139 | MAP2K1 | 0.32422237 |
140 | DAPK3 | 0.32022257 |
141 | NLK | 0.31908042 |
142 | ROCK2 | 0.31448772 |
143 | PRKACB | 0.29174986 |
144 | TRPM7 | 0.27683601 |
145 | TRIM28 | 0.27603260 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Nicotine addiction_Homo sapiens_hsa05033 | 4.08882441 |
2 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 3.00593159 |
3 | Long-term potentiation_Homo sapiens_hsa04720 | 2.93573345 |
4 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.90533877 |
5 | Circadian entrainment_Homo sapiens_hsa04713 | 2.78547836 |
6 | Glutamatergic synapse_Homo sapiens_hsa04724 | 2.73074849 |
7 | GABAergic synapse_Homo sapiens_hsa04727 | 2.66060404 |
8 | Morphine addiction_Homo sapiens_hsa05032 | 2.65445985 |
9 | Olfactory transduction_Homo sapiens_hsa04740 | 2.63348221 |
10 | Amphetamine addiction_Homo sapiens_hsa05031 | 2.60120057 |
11 | Salivary secretion_Homo sapiens_hsa04970 | 2.29676305 |
12 | Dopaminergic synapse_Homo sapiens_hsa04728 | 2.20684691 |
13 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.98026498 |
14 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.97153551 |
15 | Renin secretion_Homo sapiens_hsa04924 | 1.96412562 |
16 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.94582622 |
17 | Taste transduction_Homo sapiens_hsa04742 | 1.91528365 |
18 | Insulin secretion_Homo sapiens_hsa04911 | 1.91215795 |
19 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.88628934 |
20 | Long-term depression_Homo sapiens_hsa04730 | 1.88577839 |
21 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.87853699 |
22 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.87423119 |
23 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.84568444 |
24 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.81842524 |
25 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.76290386 |
26 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.72484200 |
27 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.69590648 |
28 | Ether lipid metabolism_Homo sapiens_hsa00565 | 1.66561724 |
29 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.64622218 |
30 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.56224921 |
31 | Cocaine addiction_Homo sapiens_hsa05030 | 1.56117183 |
32 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.44169955 |
33 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.40014907 |
34 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.38431205 |
35 | Gap junction_Homo sapiens_hsa04540 | 1.34761424 |
36 | ABC transporters_Homo sapiens_hsa02010 | 1.32019327 |
37 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.31087031 |
38 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.30373338 |
39 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.29467838 |
40 | Axon guidance_Homo sapiens_hsa04360 | 1.25765272 |
41 | Phototransduction_Homo sapiens_hsa04744 | 1.25063175 |
42 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.22791741 |
43 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.17360089 |
44 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 1.16133962 |
45 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 1.14040600 |
46 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.13550797 |
47 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.12726596 |
48 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.11464843 |
49 | Glioma_Homo sapiens_hsa05214 | 1.11033436 |
50 | ErbB signaling pathway_Homo sapiens_hsa04012 | 1.08323785 |
51 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.08024629 |
52 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.07885752 |
53 | Melanogenesis_Homo sapiens_hsa04916 | 1.07323586 |
54 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 1.01473402 |
55 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.94592212 |
56 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.89038038 |
57 | Histidine metabolism_Homo sapiens_hsa00340 | 0.86934531 |
58 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.86372389 |
59 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.85989328 |
60 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.84724863 |
61 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.82944378 |
62 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.82276622 |
63 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.81262985 |
64 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.79730031 |
65 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.78222380 |
66 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.76173387 |
67 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.74554161 |
68 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.74461215 |
69 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.74108871 |
70 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.74035510 |
71 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.73757507 |
72 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.73641567 |
73 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.71579689 |
74 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.70959193 |
75 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.70165265 |
76 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.69105133 |
77 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.68763925 |
78 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.67147238 |
79 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.66936503 |
80 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.66411761 |
81 | Mineral absorption_Homo sapiens_hsa04978 | 0.65986099 |
82 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.65869524 |
83 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.65237480 |
84 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.65209487 |
85 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.63401887 |
86 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.62528890 |
87 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.60559802 |
88 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.56944427 |
89 | Circadian rhythm_Homo sapiens_hsa04710 | 0.56883864 |
90 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.56299700 |
91 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.56135865 |
92 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.56128297 |
93 | Alzheimers disease_Homo sapiens_hsa05010 | 0.54667214 |
94 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.53636831 |
95 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.51847282 |
96 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.51692521 |
97 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.51467831 |
98 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.51301956 |
99 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.49272373 |
100 | Retinol metabolism_Homo sapiens_hsa00830 | 0.48216959 |
101 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.47808618 |
102 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.46720686 |
103 | Alcoholism_Homo sapiens_hsa05034 | 0.45720122 |
104 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.44382673 |
105 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.44275788 |
106 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.43010330 |
107 | Basal transcription factors_Homo sapiens_hsa03022 | 0.42998324 |
108 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.42075713 |
109 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.40626824 |
110 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.39191457 |
111 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.39132169 |
112 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.37194730 |
113 | Endometrial cancer_Homo sapiens_hsa05213 | 0.37140558 |
114 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.36681378 |
115 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.36409072 |
116 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.35955379 |
117 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.35543948 |
118 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.35453864 |
119 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.34897470 |
120 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.33535212 |
121 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.33237769 |
122 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.33021831 |
123 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.32935889 |
124 | Peroxisome_Homo sapiens_hsa04146 | 0.31989432 |
125 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.31639871 |
126 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.31396491 |
127 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.31256768 |
128 | Prion diseases_Homo sapiens_hsa05020 | 0.30102268 |
129 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.28928630 |
130 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.28632287 |
131 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.28571977 |
132 | Endocytosis_Homo sapiens_hsa04144 | 0.28003881 |
133 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.27772710 |
134 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.26523212 |
135 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.26274216 |
136 | Bile secretion_Homo sapiens_hsa04976 | 0.21923192 |